Corvia Medical
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Highwood Dr Ste 300, Tewksbury, Massac...Phone Number
(978) 654-6123Website
www.corviamedical.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Corvia Medical
Corvia Medical, Inc. is revolutionizing the treatment of heart failure through novel transcatheter cardiovascular devices. Corvia Medical is a medical device company dedicated to improving treatment for patients with heart failure, particularly those with preserved or mildly reduced ejection fraction.Explore more
Corvia Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Corvia Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Corvia Medical is spiking on competitors!
Product Launch: Get notified when Corvia Medical launches new products
Earning: See what the market has to say on Corvia Medical recently announced quarterly report
Corvia Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Corvia Medical had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Corvia Medical
Check if Corvia Medical has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Corvia Medical has new funding data
Recommended Actions
Find VP level buyers at Corvia Medical
Find 2 more new buyers
Compare Similar Companies to Corvia Medical
Compare insights from companies similar to Corvia Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Corvia Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Corvia Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Corvia Medical.
Corvia Medical financials insights
Gather financial insights about Corvia Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Series A
$5.4M
2012
Series B
$9M
2013
Series C
$10.7M
2014
Series D
$34M
2022
Unspecified
$54M
2025
Other Financing Round
$55M
Corvia Medical Tech Stack
A closer look at the technologies used by Corvia Medical
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Mergers & Acquisitions, Retail/Store Systems, Events, eCommerce, Training, Sales, Financial Systems, Software, Store Operations, Field Marketing, Finance, Financial Transactions
Event
Mergers & Acquisitions, Retail/Store Systems, Events, eCommerce, Training, Sales, Financial Systems, Software, Store Operations, Field Marketing, Finance, Financial Transactions
Funding
Funding
Corvia Medical News & Media
Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt
Existing investors provide funding to finish international RESPONDER-HF trial TEWKSBURY, Mass., June 17, 2025 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from...Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards
Commercial validation in Europe parallels ongoing RESPONDER-HF clinical trial TEWKSBURY, Mass., Dec. 21, 2024 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure, announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745). The Corvia Atrial Shunt is a catheter-based cardiac implant designed to reduce heart failure symptoms by lowering pressures in tCorvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients
44% reduction in total heart failure event rate and ongoing improvements in quality of life in responder group patients implanted with shunt TEWKSBURY, Mass., Oct. 25, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced impressive three-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt in selected heart failure patients with preserved (HFpENewly Published Data in JAMA Cardiology Demonstrates Favorable Long-term Effects of the Corvia Atrial Shunt in Heart Failure Patients
Two years of echocardiographic data affirm positive effects of atrial shunt therapy on heart structure and function TEWKSBURY, Mass., May 7, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Corvia Medical
Sign Up For FreeTo access detailed company insights
Corvia Medical, Inc. is revolutionizing the treatment of heart failure through novel transcatheter cardiovascular devices. Corvia Medical is a medical device company dedicated to improving treatment for patients with heart failure, particularly those with preserved or mildly reduced ejection fraction.... Read More
